Reply to Virojanapirom et al

Affiliations

Comment

Kentaro Yamada et al. J Infect Dis. 2016.

. 2016 Aug 1;214(3):503.

doi: 10.1093/infdis/jiw175. Epub 2016 May 6.

¹ Department of Microbiology.
² Department of Infectious Diseases, Faculty of Medicine, Oita University, Japan.

No abstract available

Comment on

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.
Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A. Yamada K, et al. J Infect Dis. 2016 Apr 15;213(8):1253-61. doi: 10.1093/infdis/jiv586. Epub 2015 Dec 9. J Infect Dis. 2016. PMID: 26655300 Free PMC article.
T-705 as a Potential Therapeutic Agent for Rabies.
Virojanapirom P, Lumlertdacha B, Wipattanakitchareon A, Hemachudha T. Virojanapirom P, et al. J Infect Dis. 2016 Aug 1;214(3):502-3. doi: 10.1093/infdis/jiw174. Epub 2016 May 6. J Infect Dis. 2016. PMID: 27190188 No abstract available.